微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 57.29% | 0.58% | -0.79% | 64/141 | 52.4% | 佰仁医疗 | 88.71% | 行业排名> |
| 2026-03-31 | 57.74% | 1.73% | -2.08% | 62/141 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 58.97% | 7% | 5.42% | 58/141 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 55.94% | -2.2% | -1.8% | 64/141 | 52.23% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 56.96% | -0.07% | 0.35% | 64/141 | 52.48% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 56.76% | -1.13% | 2.99% | 62/141 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 55.11% | -0.28% | -3.64% | 68/141 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 57.19% | 4.11% | 0.34% | 63/141 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 57% | 6.78% | -0.72% | 64/141 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 57.41% | 3.77% | 3.88% | 63/141 | 53.88% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 55.27% | 1.93% | 0.61% | 69/141 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 54.93% | 4.06% | 2.91% | 67/141 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 53.38% | -1.77% | -3.52% | 68/141 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 55.33% | 1.71% | 2.03% | 67/141 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 54.22% | -6.43% | 2.72% | 67/141 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 52.79% | -9.5% | -2.86% | 75/141 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 54.34% | -6.46% | -0.1% | 73/141 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 54.4% | -9.77% | -6.13% | 68/141 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 57.95% | 9.09% | -0.66% | 71/141 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 58.33% | 9.3% | 0.4% | 63/141 | 59.77% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 58.1% | 11.05% | -3.63% | 69/141 | 59.05% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 60.28% | 20.75% | 13.49% | 56/141 | 61.5% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 53.12% | 2.52% | -0.46% | 83/141 | 60.12% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 53.37% | 1.14% | 2% | 63/141 | 62.21% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 52.32% | -1.42% | 4.8% | 77/141 | 60.36% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 49.92% | -3.69% | -3.66% | 50/141 | 58.8% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 51.82% | 0.03% | -1.8% | 68/141 | 56.96% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 52.76% | 0.95% | -0.58% | 35/141 | 55.83% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 53.07% | 2.04% | 2.39% | 43/141 | 57.93% | 正海生物 | 93.09% | 行业排名> |
| 2019-03-31 | 51.84% | -2.1% | 0.07% | 26/141 | 52.61% | 正海生物 | 93.85% | 行业排名> |
| 2018-12-31 | 51.8% | -3.63% | -0.89% | 61/141 | 56.22% | 正海生物 | 93.08% | 行业排名> |
| 2018-09-30 | 52.27% | -1.66% | 0.49% | 26/141 | 52.76% | 正海生物 | 92.83% | 行业排名> |
| 2018-06-30 | 52.01% | -1.05% | -1.77% | 30/141 | 53.06% | 正海生物 | 92.44% | 行业排名> |
| 2018-03-31 | 52.95% | -1.76% | -1.5% | 25/141 | 52.55% | 正海生物 | 92.7% | 行业排名> |
| 2017-12-31 | 53.75% | -0.63% | 1.13% | 57/141 | 56.1% | 正海生物 | 93.67% | 行业排名> |
| 2017-09-30 | 53.15% | -2.63% | 1.12% | 23/141 | 53.53% | 正海生物 | 94.14% | 行业排名> |
| 2017-06-30 | 52.57% | -3.22% | -2.47% | 32/141 | 54.85% | 正海生物 | 93.83% | 行业排名> |
| 2017-03-31 | 53.9% | 5.41% | -0.37% | 23/141 | 54.29% | 正海生物 | 93.69% | 行业排名> |
| 2016-12-31 | 54.1% | -5.04% | -0.9% | 45/141 | 57.35% | 正海生物 | 92.79% | 行业排名> |
| 2016-09-30 | 54.59% | -6.03% | 0.5% | 18/141 | 51.85% | 健帆生物 | 84.23% | 行业排名> |
| 2016-06-30 | 54.31% | -3.61% | 6.22% | 24/141 | 52.6% | *ST明德 | 86.71% | 行业排名> |
| 2016-03-31 | 51.13% | -9.26% | -10.24% | 16/141 | 50.24% | 健帆生物 | 83.86% | 行业排名> |